CNTG - CENTOGENE Company Long-Term Debts

Graphic logo of CENTOGENE (CNTG)

This chart illustrating the historical value of long-term liabilities for Centogene N.V. (CNTG), a company specializing in laboratory diagnostics, is 0.00. High barriers to entry are maintained by an exclusive array of genetic data and strict HIPAA oversight. Despite its status as an indispensable partner for Big Pharma in the rare pathology segment, management is currently struggling with a liquidity shortage and is reviewing its debt load.

CNTG Centogene NV: Company Long-Term Debts in the range 07/04/2022 - 08/17/2024

Financial and market metric breakdowns for centogene.com (CNTG)

- price and consensus price forecast:
Share Price Centogene|CNTG - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization CENTOGENE|CNTG - Total Company Value
- book capitalization data:
Equity per Share CENTOGENE|CNTG - Book Capitalization|Market Capitalization to Book Value Ratio centogene.com|CNTG - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Centogene N.V.|CNTG - Long-Term Debt to Equity Ratio|Current Liabilities to Capital CENTOGENE|CNTG - Company Debts|Debts to Net Assets CENTOGENE|CNTG - Company Long-Term Debts|Short-Term Debt Volume CENTOGENE
General company analysis:CNTG (Centogene NV)
Mass-produced product of CENTOGENE, N.V.

Investors view Centogene N.V. (CNTG) as a stable defensive asset within the genetics sector. This indicator captures the volume of confirmed credit obligations with maturities exceeding one year. Analyzing the firm's long-term debt statistics reveals sharp shifts in its financing structure. For a business dependent on grants and partnerships, such fluctuations reflect the scale of research investments. Monitoring this metric confirms the company's long-term solvency.

Competing companies

Company Long-Term Indebtedness agilent.com A|Quest Diagnostics Incorporated - Company Long-Term Debts|ILMN: Company Long-Term Debts|Company Long-Term Debt Cologuard|Revvity Corp (RVTY) - Company Long-Term Indebtedness|BIO (Bio-Rad Laboratories) - Company Long-Term Debts|Company Long-Term Debts NNNN|Company Long-Term Debt Sotera Health (SHC)|Company Long-Term Debt Quidel Corporation QDEL|OPK: Company Long-Term Liabilities|CareDx - Long-Term Debt|Company Long-Term Debt MRVI (Maravai LifeSciences)|FLGT - Long-Term Debt Volume|Standard BioTools - Company Long-Term Debts|CTKB (Cytek Biosciences Inc) - Long-Term Debt Volume|OSUR: Company Long-Term Debt|Long-Term Debt Volume Exagen Diagnostics|Company Long-Term Debts MDXH (MDxHealth SA)|Company Long-Term Liabilities luciddx.com (LUCD)|PRE: Company Long-Term Debts|Insight Molecular Diagnostics, Inc. - Long-Term Debt|Trinity Biotech Corp (TRIB) - Company Long-Term Debt|ProPhase Labs Corp (PRPH) - Company Long-Term Indebtedness|AIMD - Company Long-Term Liabilities|CODX (codiagnostics.com) - Amount of Long-Term Liabilities|Company Long-Term Debt HSCS (HeartSciences)|Long-Term Debt Biomerica Inc.|CDIO: Company Long-Term Debts|Long-Term Indebtedness Virax Biolabs Corp (VRAX)|BJDX: Company Long-Term Debts|aspirawh.com - Long-Term Debt|Accelerate Diagnostics, Inc. (AXDX) - Company Long-Term Debt|ENZ - Company Long-Term Indebtedness|Company Long-Term Debts FRES|Long-Term Debt Genetic Technologies Limited|ME - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings PMD